- Home
- GTEC vs RVPH Comparison
GTEC vs RVPH Comparison
Compare GTEC & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- RVPH
- Stock Information
- Founded
- GTEC 2006
- RVPH 2006
- Country
- GTEC United States
- RVPH United States
- Employees
- GTEC N/A
- RVPH N/A
- Industry
- GTEC Industrial Machinery/Components
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- RVPH Health Care
- Exchange
- GTEC Nasdaq
- RVPH Nasdaq
- Market Cap
- GTEC 21.2M
- RVPH 30.1M
- IPO Year
- GTEC N/A
- RVPH N/A
- Fundamental
- Price
- GTEC $1.40
- RVPH $0.42
- Analyst Decision
- GTEC
- RVPH Strong Buy
- Analyst Count
- GTEC 0
- RVPH 5
- Target Price
- GTEC N/A
- RVPH $5.20
- AVG Volume (30 Days)
- GTEC 101.7K
- RVPH 1.3M
- Earning Date
- GTEC 11-13-2025
- RVPH 11-13-2025
- Dividend Yield
- GTEC N/A
- RVPH N/A
- EPS Growth
- GTEC N/A
- RVPH N/A
- EPS
- GTEC 0.53
- RVPH N/A
- Revenue
- GTEC $81,601,160.00
- RVPH N/A
- Revenue This Year
- GTEC $3.28
- RVPH N/A
- Revenue Next Year
- GTEC N/A
- RVPH N/A
- P/E Ratio
- GTEC $2.59
- RVPH N/A
- Revenue Growth
- GTEC N/A
- RVPH N/A
- 52 Week Low
- GTEC $1.14
- RVPH $0.30
- 52 Week High
- GTEC $2.92
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- GTEC 50.94
- RVPH 40.23
- Support Level
- GTEC $1.29
- RVPH $0.50
- Resistance Level
- GTEC $1.39
- RVPH $0.47
- Average True Range (ATR)
- GTEC 0.06
- RVPH 0.03
- MACD
- GTEC 0.02
- RVPH -0.01
- Stochastic Oscillator
- GTEC 88.70
- RVPH 32.67
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.